Barclays’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-72,825
Closed -$9.61M 7602
2018
Q4
$9.61M Buy
72,825
+34,325
+89% +$4.4M 0.01% 1172
2018
Q3
$5.14M Sell
38,500
-112,798
-75% -$16.9M ﹤0.01% 1791
2018
Q2
$24.1M Buy
151,298
+110,301
+269% +$16.4M 0.02% 690
2018
Q1
$5.86M Sell
40,997
-131,335
-76% -$17.9M ﹤0.01% 1528
2017
Q4
$22.9M Buy
172,332
+144,756
+525% +$18.5M 0.02% 736
2017
Q3
$3.43M Buy
27,576
+12,531
+83% +$1.73M ﹤0.01% 1833
2017
Q2
$2.12M Sell
15,045
-14,592
-49% -$1.82M ﹤0.01% 2193
2017
Q1
$3.34M Sell
29,637
-137,944
-82% -$16.1M ﹤0.01% 1625
2016
Q4
$17.6M Buy
167,581
+122,937
+275% +$13.2M 0.02% 652
2016
Q3
$5.63M Buy
44,644
+4,784
+12% +$609K 0.01% 1207
2016
Q2
$5.5M Buy
39,860
+15,664
+65% +$2.07M 0.01% 1234
2016
Q1
$3.34M Sell
24,196
-7,997
-25% -$1.1M 0.01% 1498
2015
Q4
$5.15M Sell
32,193
-6,844
-18% -$1.06M 0.01% 1296
2015
Q3
$5.19M Sell
39,037
-2,675
-6% -$349K 0.01% 1347
2015
Q2
$4.75M Buy
41,712
+2,564
+7% +$307K 0.01% 1523
2015
Q1
$4.66M Buy
39,148
+1,416
+4% +$189K 0.01% 1617
2014
Q4
$5.47M Buy
37,732
+6,787
+22% +$852K 0.01% 1628
2014
Q3
$4.05M Sell
30,945
-23,993
-44% -$3.16M ﹤0.01% 1982
2014
Q2
$6.87M Sell
54,938
-125,241
-70% -$16.2M 0.01% 1456
2014
Q1
$28.8M Buy
180,179
+159,373
+766% +$26.2M 0.03% 506
2013
Q4
$2.79M Sell
20,806
-9,592
-32% -$1.23M ﹤0.01% 2335
2013
Q3
$3.28M Sell
30,398
-21,049
-41% -$2.28M ﹤0.01% 2075
2013
Q2
$4.36M Buy
+51,447
New +$4.6M 0.01% 1737

Barclays's ATHN Position: Q1 2019 in Review

Barclays sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 72,825 shares — an estimated $9.61M sold.

Barclays first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $28.8M in Q1 2014. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Barclays reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Barclays sold 72,825 Athenahealth, Inc. shares in Q1 2019, an estimated $9.61M.
  • Barclays first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
  • Barclays's Athenahealth, Inc. position peaked at $28.8M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.